HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Andreas Chott Selected Research

Marginal Zone B-Cell Lymphoma (MALT Lymphoma)

6/2015Antibiotic treatment as sole management of Helicobacter pylori-negative gastric MALT lymphoma: a single center experience with prolonged follow-up.
5/2012Plasmacytic differentiation in MALT lymphomas following treatment with rituximab.
5/2009A phase II study of bortezomib in patients with MALT lymphoma.
1/2007Second complete remission of Helicobacter pylori negative gastric MALT lymphoma following antibiotic treatment.
10/2006Reverse transcription-PCR for t(11;18)(q21;q21) staging and monitoring in mucosa-associated lymphoid tissue lymphoma.
7/2006Assessment of disease dissemination in gastric compared with extragastric mucosa-associated lymphoid tissue lymphoma using extensive staging: a single-center experience.
3/2006Antibiotic treatment is not effective in patients infected with Helicobacter pylori suffering from extragastric MALT lymphoma.
3/2006Marginal zone lymphoma of the lacrimal gland spreading to the lung and the bone marrow 11 years after first symptoms.
1/2006Activity of rituximab plus cyclophosphamide, doxorubicin/mitoxantrone, vincristine and prednisone in patients with relapsed MALT lymphoma.
11/2005Transformation of MALT lymphoma to pure plasma cell histology following treatment with the anti-CD20 antibody rituximab.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Andreas Chott Research Topics

Disease

19Lymphoma (Lymphomas)
12/2020 - 01/2002
18Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
06/2015 - 09/2002
7Neoplasms (Cancer)
01/2020 - 01/2002
4Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
01/2020 - 05/2004
4Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
02/2014 - 10/2004
3Non-Hodgkin Lymphoma (Lymphosarcoma)
07/2015 - 01/2002
3Celiac Disease (Celiac Sprue)
02/2014 - 02/2004
2Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
07/2015 - 03/2014
2Multiple Myeloma
07/2011 - 02/2003
2Trisomy (Trisomies)
06/2010 - 03/2006
2T-Cell Lymphoma (Lymphoma, T Cell)
04/2010 - 05/2004
2Hodgkin Disease (Hodgkin's Disease)
09/2008 - 01/2002
2Paraproteinemias (Monoclonal Gammopathy)
03/2007 - 11/2004
2Plasmacytoma
03/2007 - 11/2005
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
07/2004 - 05/2003
2Systemic Mastocytosis
07/2003 - 03/2002
2Osteosarcoma (Osteogenic Sarcoma)
01/2003 - 10/2002
1Hematologic Neoplasms (Hematological Malignancy)
01/2020
1Colorectal Neoplasms (Colorectal Cancer)
01/2016
1B-Cell Lymphoma (Lymphoma, B Cell)
07/2015
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
07/2015
1Familial primary gastric lymphoma
06/2015
1Clostridium Infections
09/2014
1Sexually Transmitted Diseases (Sexually Transmitted Disease)
08/2013
1Intestinal Perforation
01/2012
1Enteropathy-Associated T-Cell Lymphoma
01/2012
1Carcinoma (Carcinomatosis)
10/2011
1Urinary Bladder Neoplasms (Bladder Cancer)
10/2011
1Neoplasm Metastasis (Metastasis)
06/2011
1Trisomy 18 Syndrome
06/2010
1Epstein-Barr Virus Infections
04/2010
1Diarrhea
05/2009
1Exanthema (Rash)
06/2008
1Lymphadenopathy
06/2008
1Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
03/2008
1Pseudolymphoma
12/2007
1Disease Progression
09/2007
1Infections
03/2006
1Dacryocystitis (Dacryoadenitis)
03/2006
1Genetic Translocation (Chromosomal Translocation)
02/2005

Drug/Important Bio-Agent (IBA)

7Rituximab (Mabthera)FDA Link
07/2015 - 01/2003
4Anti-Bacterial Agents (Antibiotics)IBA
06/2015 - 03/2006
4Proteins (Proteins, Gene)FDA Link
03/2010 - 10/2002
3CladribineFDA LinkGeneric
01/2012 - 09/2002
3RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
07/2006 - 03/2003
2AntibodiesIBA
02/2014 - 08/2013
2DNA (Deoxyribonucleic Acid)IBA
02/2014 - 09/2008
2LigandsIBA
10/2011 - 01/2003
2Bortezomib (Velcade)FDA Link
07/2011 - 05/2009
2Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA
06/2010 - 03/2006
2Tryptases (Tryptase)IBA
06/2008 - 07/2003
2Prednisone (Sone)FDA LinkGeneric
01/2006 - 02/2005
2Mitoxantrone (Novantrone)FDA LinkGeneric
01/2006 - 02/2005
2Thalidomide (Thalomid)FDA Link
09/2005 - 10/2004
2NucleosidesIBA
01/2004 - 09/2002
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2003 - 10/2002
1Methotrexate (Mexate)FDA LinkGeneric
12/2020
1Transcription Factors (Transcription Factor)IBA
01/2020
1Janus Kinase InhibitorsIBA
01/2020
1ruxolitinibIBA
01/2020
1Biological ProductsIBA
08/2017
1pembrolizumabIBA
01/2016
1Moxifloxacin (Avelox)FDA Link
09/2014
1Cyclin D1IBA
12/2012
1CyclinsIBA
12/2012
1IceIBA
01/2012
1CarbohydratesIBA
10/2011
1Peanut AgglutininIBA
10/2011
1EnzymesIBA
10/2011
1Plant LectinsIBA
10/2011
1LectinsIBA
10/2011
1Monensin (Coban)IBA
10/2011
1Proteasome InhibitorsIBA
07/2011
1Dexamethasone (Maxidex)FDA LinkGeneric
07/2011
1gamma-delta T-Cell Antigen Receptors (T-Cell Receptor delta-Chain)IBA
04/2010
1Inducible T-Cell Co-Stimulator ProteinIBA
03/2010
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
09/2009
1OligonucleotidesIBA
09/2008
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
02/2008
1VaccinesIBA
12/2007
1Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)IBA
09/2007
1HLA-DQB1 antigen (HLA DQB1)IBA
05/2007
1ParaffinIBA
10/2006
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2006
1Vincristine (Oncovin)FDA LinkGeneric
01/2006
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2006
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
11/2005
1Chlorambucil (Leukeran)FDA Link
02/2005
1Antigen Receptors (Antigen Receptor)IBA
02/2005
1ParaproteinsIBA
11/2004
1Immunoglobulins (Immunoglobulin)IBA
11/2004

Therapy/Procedure

15Therapeutics
07/2015 - 01/2003
13Drug Therapy (Chemotherapy)
12/2020 - 09/2002
1Lasers (Laser)
03/2014
1Lymph Node Excision (Lymph Node Dissection)
06/2011
1Drug Tapering
05/2009
1Splenectomy
03/2008
1Adenoidectomy
03/2007
1Radiotherapy
03/2006
1Aftercare (After-Treatment)
09/2005